Cover Image
Market Research Report
Product code 
1063703

Ankylosing Spondylitis Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

Published: | Infinium Global Research (IGR) | 100 Pages | Delivery time: 1-2 business days

Price

Back to Top
Ankylosing Spondylitis Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027
Published: February 16, 2022
Infinium Global Research (IGR)
Content info: 100 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The report on the global ankylosing spondylitis drugs market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global ankylosing spondylitis drugs market to grow with a CAGR of 9% over the forecast period from 2021-2027. The study on ankylosing spondylitis drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on ankylosing spondylitis drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global ankylosing spondylitis drugs market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global ankylosing spondylitis drugs market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The growing FDA approval for different drugs for ankylosing spondylitis is the key factor to drive the growth of the global market.
  • The rising awareness among the population related to this disorder and its treatment is another factor contributing to the growth of the ankylosing spondylitis market across the globe

2) Restraints

  • Advancement in pain-relieving treatment has made it slow the progression of ankylosing spondylitis, a complete cure is yet not available which is a restraining factor to the growth of the global market

3) Opportunities

  • The expansion of the health care sector and increasing focus on R & D activities by the major market players will create an opportunity for ankylosing spondylitis drugs market

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global ankylosing spondylitis drugs market is segmented on the basis of drug class, and distribution channel.

The Global Ankylosing Spondylitis Drugs Market by Drug Class

  • NSAIDs
  • TNF Inhibitors
  • Immunosuppressive Drugs
  • TNF Blockers
  • JAK Inhibitors
  • Steroids
  • Others

The Global Ankylosing Spondylitis Drugs Market by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Company Profiles

The companies covered in the report include

  • Pfizer Inc
  • Merck & Co
  • Boehringer Ingelheim
  • UCB
  • Biotech, Inc.
  • Johnson & Johnson
  • Abbvie
  • Hetero
  • Zydus Cadila
  • Izana Bioscience

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the ankylosing spondylitis drugs market.

2. Complete coverage of all the segments in the ankylosing spondylitis drugs market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global ankylosing spondylitis drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Product Code: HC08744

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Ankylosing Spondylitis Drugs Market Highlights
  • 2.2. Ankylosing Spondylitis Drugs Market Projection
  • 2.3. Ankylosing Spondylitis Drugs Market Regional Highlights

3. Global Ankylosing Spondylitis Drugs Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Ankylosing Spondylitis Drugs Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Drug Class
    • 3.5.2. IGR-Growth Matrix Analysis by Distribution Channel
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Ankylosing Spondylitis Drugs Market

4. Ankylosing Spondylitis Drugs Market Macro Indicator Analysis

5. Global Ankylosing Spondylitis Drugs Market by Drug Class

  • 5.1. NSAIDs
  • 5.2. TNF Inhibitors
  • 5.3. Immunosuppressive Drugs
  • 5.4. TNF Blockers
  • 5.5. JAK Inhibitors
  • 5.6. Steroids
  • 5.7. Others

6. Global Ankylosing Spondylitis Drugs Market by Distribution Channel

  • 6.1. Hospital Pharmacy
  • 6.2. Retail Pharmacy
  • 6.3. Online Pharmacy

7. Global Ankylosing Spondylitis Drugs Market by Region 2021-2027

  • 7.1. North America
    • 7.1.1. North America Ankylosing Spondylitis Drugs Market by Drug Class
    • 7.1.2. North America Ankylosing Spondylitis Drugs Market by Distribution Channel
    • 7.1.3. North America Ankylosing Spondylitis Drugs Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Ankylosing Spondylitis Drugs Market by Drug Class
    • 7.2.2. Europe Ankylosing Spondylitis Drugs Market by Distribution Channel
    • 7.2.3. Europe Ankylosing Spondylitis Drugs Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Ankylosing Spondylitis Drugs Market by Drug Class
    • 7.3.2. Asia-Pacific Ankylosing Spondylitis Drugs Market by Distribution Channel
    • 7.3.3. Asia-Pacific Ankylosing Spondylitis Drugs Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Ankylosing Spondylitis Drugs Market by Drug Class
    • 7.4.2. RoW Ankylosing Spondylitis Drugs Market by Distribution Channel
    • 7.4.3. RoW Ankylosing Spondylitis Drugs Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Ankylosing Spondylitis Drugs Market
  • 8.2. Companies Profiles
    • 8.2.1. Pfizer Inc
    • 8.2.2. Merck & Co
    • 8.2.3. Boehringer Ingelheim
    • 8.2.4. UCB
    • 8.2.5. Biotech, Inc.
    • 8.2.6. Johnson & Johnson
    • 8.2.7. Abbvie
    • 8.2.8. Hetero
    • 8.2.9. Zydus Cadila
    • 8.2.10. Izana Bioscience